( February 11, 2026, 2:02 PM EST) -- PHILADELPHIA — A Pennsylvania federal judge on Feb. 10 denied a company and its affiliated dermatology practices’ motion for judgment on the pleadings or dismissal in a relator’s suit asserting violations of the False Claims Act (FCA) and similar state laws for the practices’ alleged fraudulent billing to receive higher reimbursements from government health insurers, finding that the FCA’s qui tam provisions “did not usurp the executive branch’s control of its enforcement priorities” and the relators’ suit “does not violate the Appointments, Vesting, and Take Care Clauses” of Article II of the U.S. Constitution....